These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31940972)

  • 1. Multiple Myeloma and Thrombosis: Prophylaxis and Risk Prediction Tools.
    Fotiou D; Gavriatopoulou M; Terpos E
    Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31940972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates on thrombotic events associated with multiple myeloma.
    Fotiou D; Gavriatopoulou M; Ntanasis-Stathopoulos I; Migkou M; Dimopoulos MA; Terpos E
    Expert Rev Hematol; 2019 May; 12(5):355-365. PubMed ID: 30957573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct oral anticoagulants for treatment and prevention of venous thromboembolism in cancer patients.
    Song AB; Rosovsky RP; Connors JM; Al-Samkari H
    Vasc Health Risk Manag; 2019; 15():175-186. PubMed ID: 31417269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines.
    Charalampous C; Shah D; Kumar S; Chakraborty R
    Ann Hematol; 2024 Apr; ():. PubMed ID: 38630132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations.
    Swan D; Rocci A; Bradbury C; Thachil J
    Br J Haematol; 2018 Nov; 183(4):538-556. PubMed ID: 30450656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis.
    Dufrost V; Risse J; Reshetnyak T; Satybaldyeva M; Du Y; Yan XX; Salta S; Gerotziafas G; Jing ZC; Elalamy I; Wahl D; Zuily S
    Autoimmun Rev; 2018 Oct; 17(10):1011-1021. PubMed ID: 30103045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended thromboprophylaxis in the acutely ill medical patient after hospitalization - a paradigm shift in post-discharge thromboprophylaxis.
    Mahan CE; Burnett AE; Fletcher ML; Spyropoulos AC
    Hosp Pract (1995); 2018 Feb; 46(1):5-15. PubMed ID: 29171776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Direct oral anticoagulants for thromboprophylaxis in ambulatory patients with cancer.
    Wang Y; Wang M; Ni Y; Liang Z
    Hematology; 2020 Dec; 25(1):63-70. PubMed ID: 31984870
    [No Abstract]   [Full Text] [Related]  

  • 9. Approach to Contemporary Risk Assessment, Prevention and Management of Thrombotic Complications in Multiple Myeloma.
    Fotiou D; Dimopoulos MA; Kastritis E
    Cancers (Basel); 2022 Dec; 14(24):. PubMed ID: 36551701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombosis in cancer: an update on prevention, treatment, and survival benefits of anticoagulants.
    Lee AY
    Hematology Am Soc Hematol Educ Program; 2010; 2010():144-9. PubMed ID: 21239784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myeloma and thrombotic complications.
    Tzoran I; Brenner B; Hoffman R
    Minerva Med; 2013 Apr; 104(2):155-60. PubMed ID: 23514991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods, oral anticoagulation, dextran and regional anaesthesia as thromboprophylaxis.
    Roderick P; Ferris G; Wilson K; Halls H; Jackson D; Collins R; Baigent C
    Health Technol Assess; 2005 Dec; 9(49):iii-iv, ix-x, 1-78. PubMed ID: 16336844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Venous thromboembolism in cancer patients - risk scores and recent randomised controlled trials.
    Thaler J; Ay C; Pabinger I
    Thromb Haemost; 2012 Dec; 108(6):1042-8. PubMed ID: 22836491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of thrombosis with lenalidomide and its prevention with aspirin.
    Hirsh J
    Chest; 2007 Jan; 131(1):275-7. PubMed ID: 17218586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysis.
    Cimminiello C; Prandoni P; Agnelli G; Di Minno G; Polo Friz H; Scaglione F; Boracchi P; Marano G; Harenberg J
    Intern Emerg Med; 2017 Dec; 12(8):1291-1305. PubMed ID: 28756546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do we need prophylactic anticoagulation in ambulatory patients with lung cancer? A review.
    Dimakakos E; Kotteas E; Gomatou G; Katsarou T; Vlahakos V; Vathiotis I; Talagani S; Dimitroulis I; Syrigos K
    Vasc Med; 2020 Jun; 25(3):255-262. PubMed ID: 32146869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboprophylaxis in multiple myeloma patients treated with lenalidomide - A systematic review.
    Al-Ani F; Bermejo JM; Mateos MV; Louzada M
    Thromb Res; 2016 May; 141():84-90. PubMed ID: 26986753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Oral Anticoagulants and the Paradigm Shift in the Management of Venous Thromboembolism.
    Lim HY; Nandurkar H; Ho P
    Semin Thromb Hemost; 2018 Apr; 44(3):261-266. PubMed ID: 29558778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Venous thromboembolism: identifying patients at risk and establishing prophylaxis.
    Shirvanian S; Tapson VF
    Curr Med Res Opin; 2015 Dec; 31(12):2297-311. PubMed ID: 26414590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of direct oral anticoagulants versus traditional anticoagulants in venous thromboembolism.
    Giustozzi M; Franco L; Vedovati MC; Becattini C; Agnelli G
    J Thromb Thrombolysis; 2019 Oct; 48(3):439-453. PubMed ID: 31104194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.